Patients Patients want to be heard. Is pharma listening? A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Natalie Turner, director at AXON, a global healthcare communications agency.
News GSK boosts anti-infectives pipeline with Scynexis antifungal Last year, GSK said it was planning to invest a cool £1 billion in infectious d
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?